Objectives: To assess the efficacy of self-expanding metal stents (SEMS) for esophageal salvage in patients who would otherwise require esophageal/conduit resection.
See Editorial Commentary page 1151.
Intrathoracic contamination from the esophagus, whether from an anastomotic leak after gastroesophageal resection, spontaneous rupture, or iatrogenic perforation, remains a life-threatening issue, with mortality rates as high as 60%. 1 Historically, esophageal leak necessitated an aggressive surgical approach, including extensive debridement and possible esophageal diversion. Then, more conservative surgical techniques of primary anastomotic repair with tissue reinforcement, as well as nonoperative management, were successfully adapted in select cases of intrathoracic contamination. 2 More recently, endoscopic placement of fully covered and partially covered stents has been explored and developed by thoracic surgeons to control esophageal leak (both cervical and thoracic) and perforation with acceptable results. [3] [4] [5] Although the initial use of self-expanding metal stents (SEMS) was limited to palliation of tracheoesophageal fistulae from advanced malignancy, [6] [7] [8] SEMS has since been used as an efficacious modality to control esophageal leak in the setting of anastomotic leak after esophagectomy, as well as iatrogenic or spontaneous esophageal perforations. 1, [4] [5] [6] 9 In our institution, we have used covered SEMS (cSEMS) since 2007, and have reported esophageal salvage in 77% of the patients with the use of cSEMS in the past. 9 In 2010, we began using partially covered SEMS (pcSEMS) with exposed bare-metal mesh ends to promote tissue embedding. 10 Thus, in this study, we evaluated the efficacy of SEMS in the management of esophageal leakage since the introduction of pcSEMS.
METHODS
Approval for this study was obtained from the institutional review board. From January 2010 to December 2015, 83 patients with gastroesophageal leakage underwent SEMS placement by the thoracic surgeons at our hospital as the primary means of controlling intrathoracic or intraabdominal contamination. Patients were consented for off-label use of SEMS based on previous success at our institution 9 and other published studies, 4, 5 with the understanding that if they failed management with stent, they would need open surgical repair or even diversion. We retrospectively reviewed all patients in this cohort with the primary objective to evaluate the efficacy of SEMS in esophageal or conduit salvage. Patients undergoing esophageal stent placement for esophageal leak after esophagectomy, esophagojejunostomy, sleeve gastrectomy, foregut procedure, or spontaneous/iatrogenic perforation were all included in the study. We also included patients who had esophageal stricture refractory to dilation and had a stent placed as a way to salvage their native esophagus. However, patients with malignant tracheaesophageal fistula (n ¼ 6) or malignant mass causing esophageal obstruction (n ¼ 4) who had stents placed for palliative intent were excluded from the study, as they were never deemed to be candidates for resection. Reviewed data included patient demographics, SEMS characteristics, postoperative stent-specific complications, and clinical outcomes. Although failure was defined as no change in the leak size or clinical signs of ongoing infection, successful salvage was defined by number of patients who did not have to undergo esophageal resection or conduit takedown.
Statistical analyses were performed by using Microsoft Excel (Microsoft, Redmond, Wash). Data are reported as mean AE 95% confidence intervals or as median (minimum-maximum) values.
RESULTS

Patient Demographics
From January 2010 to December 2015, 83 patients were identified to have gastroesophageal leakage controlled with endoscopic placement of SEMS that met our inclusion criteria ( Table 1 ). The median age was 63 years. In this study, there were 56 (67.5%) men and 27 (32.5%) women. The comorbidities are detailed in Table 1 . A significant proportion of our patients had risk factors predisposing them to gastroesophageal leakage, particularly anastomotic leakage after esophagectomy. Of 27 patients who underwent an esophagectomy for malignancy or dysplasia, 25 patients received neoadjuvant chemoradiation, 1 patient had history of radiation therapy only, and 1 patient had history of chemotherapy alone. One patient underwent esophagectomy for a benign stricture.
Indications for endoscopic SEMS placements were iatrogenic esophageal perforation in 17 (20.5%) patients, spontaneous esophageal rupture in 19 (22.9%) patients, anastomotic leak after gastroesophageal resection in 38 (45.8%), esophageal obstruction in 8 (9.6%), and severe esophageal caustic injury from ingestion in 1 patient. Of 38 patients who had anastomotic leak after surgical resection, 22 patients had undergone Ivor Lewis esophagectomy, 5 patients 3-hole esophagectomy, 1 patient transhiatal esophagectomy, 1 patient esophagectomy with colonic interposition, 1 patient with delayed esophageal reconstruction after staged esophagectomy, 3 patients esophagojejunostomy, 3 sleeve gastrectomy, and 2 Heller myotomy with fundoplication ( Table 2 ).
Stent Characteristics
In 83 patients, a total of 148 stents were placed, which included 121 pcSEMS and 27 cSEMS ( Table 3) . Forty-eight (57.8%) patients required only 1 SEMS placement, with no replacement with additional SEMS. Seventeen patients required 2 consecutive SEMS placements, 11 patients needed 3 stents placed, and 7 patients needed 4 or more stents. During this time, we Abbreviations and Acronyms cSEMS ¼ covered self-expanding metal stents pcSEMS ¼ partially covered self-expanding metal stents SEMS ¼ self-expanding metal stents used only Ultraflex and WallFlex stents (cSEMS and pcSEMS, respectively) from Boston Scientific (Marlborough, Mass). All SEMS were placed endoscopically under fluoroscopic guidance by thoracic surgeons at our institution. The surgeon used individualized clinical judgment to determine the choices of either cSEMS or pcSEMS placement. On-table contrast studies were performed to evaluate for successful placement of SEMS to exclude the area of gastroesophageal leakage. To prevent migration, 72 SEMS were fixed with umbilical tape as described previously, 11 and 12 were fixed with the OverStitch Endoscopic Suturing System (Apollo, Austin, Tex) (Video 1). Whenever umbilical tape was used to secure the stent, it was cut 4 days after the SEMS placement to allow sufficient time for tissue embedding. However, the endoscopic suture was removed only at the time of stent removal. Patients with intrathoracic sepsis were managed with tube thoracostomy, video-assisted thoracoscopic decortication, or thoracotomy. Most SEMS were removed in 3 to 4 weeks in the operating room with reevaluation of leak with an on-table esophagram. Patients with persistent gastroesophageal leakage underwent repeat SEMS placement with reevaluation every 3 to 4 weeks until the site healed. Patients who failed conservative management with SEMS or developed deteriorating clinical status ultimately underwent esophageal diversion.
Postoperative Events
There were a total of 6 stent migrations (2 pcSEMS, 4 cSEMS), 4 of which were bridled with umbilical tape and 2 that were not fixed, resulting in a 5.6% migration incidence for SEMS fixed with umbilical tape. Interestingly, none of the 12 stents fixed with the endoluminal suturing device resulted in migration and of the stents that were not fixed, only 2 migrated, resulting in a 3.1% migration rate where both were cSEMS. When further divided, this gave us a 14.8% migration incidence for cSEMS and 1.7% for pcSEMS. Median duration of SEMS placement was 23 days, ranging 0 to 57 days. The patient with 0-day duration was a patient who had undergone a Nissen fundoplication 2 weeks earlier, who presented to our institution in extremis with severe metabolic acidosis and cardiovascular instability. Endoscopy revealed an esophageal perforation just proximal to the gastroesophageal junction with an extremely dilated and ischemic stomach. Therefore, pcSEMS was placed with the intent to emergently control the source of sepsis; however, the patient died of cardiac arrest soon after in the intensive care unit.
One of our patients who had SEMS placement for benign esophageal stricture refractory to multiple endoscopic dilations had pneumoperitoneum discovered 2 days after the stent removal secondary to a perforation in the distal esophagus just distal to the distal end of the stent. She underwent repeat SEMS placement along with gastrostomy tube placement at the time of laparoscopic abdominal A summary of post-stent complications, including migration, perforation, and inability to salvage the esophagus, is briefly summarized in Table 4 . The highest incidence of stent migration was noted to be in the postsurgical group of patients, with lowest incidence in the spontaneous perforation group.
Clinical Outcomes
The esophageal/conduit salvage success was 81.9%. There were 15 patients who failed endoscopic management with SEMS for gastroesophageal leak and ultimately required conduit takedown or esophagectomy (Table 5) . Of these 15 patients, 9 (60%) patients underwent SEMS placement more than once in an attempt to salvage the esophagus or conduit, and 6 (40%) underwent an additional drainage operation in addition to SEMS placement. The median number of days from SEMS placement to definitive resection was 24 days, ranging from 1 to 75 days. One patient with a history of intermittent dysphagia required esophagectomy only 1 day after SEMS placement. She had presented to our institution after delayed diagnosis of spontaneous esophageal perforation at another hospital. Tube thoracostomy and pcSEMS were placed emergently as a temporizing source control measure during resuscitation before definitive esophagectomy with proximal esophageal diversion. One year later, she successfully underwent reconstruction with a jejunal conduit to reestablish esophageal continuity.
DISCUSSION
In the past decade, upper gastrointestinal stents, initially developed as rigid cylinders to palliate malignant obstructions, have been modified to flexible and self-expandable forms to widen applicability and improve efficacy and safety. 12 Metal stents, characterized by their greater degree of flexibility and their ability to generate high radial forces for stent patency and position, are available as uncovered, partially covered, or fully covered. 12, 13 Compared with plastic stents with previously reported migration as high as 35%, 6 metal stents have been associated with lower incidence of migration and lower incidence of stent failure requiring reintervention. 4, 5, [12] [13] [14] Among the metal stents, uncovered SEMS are associated with the highest risk of tissue ingrowth leading to stent occlusion and with difficulty in stent removal, despite their lower rates of migration.
12,13 Therefore, we have advocated the use of either cSEMS or pcSEMS. In a previous study from our institution, 2 episodes (6.7%) of stent migration occurred among 30 patients with cSEMS placements. 9 In another study, stent migration was reported to be significantly higher with cSEMS (37.5%) versus pcSEMS (9.1%). 10 A systematic review has shown similar trend with 26% migration with cSEMS and 12% with pcSEMS reported from other institutions. 15 Since the publication of these studies, our group has published a fixation method, bridling of SEMS with umbilical tape. 11 More recently, we have adopted the use of an endoluminal suturing device (Apollo) for stent fixation (although this is not approved by the Food and Drug Administration for this purpose). During the initial employment of the bridling method, we saw complete elimination of stent migration. However, with a much larger sample size, we report 5.6% migration of stents fixed with umbilical tape, no migration of 12 stents fixed with the endoluminal suturing device, and 3.1% migration of stents that were not fixed with either method. Results in Table 4 indicate a higher incidence of stent migration in the postsurgical leak cohort and the lowest incidence in the spontaneous perforation cohort; however, these results are difficult to interpret, as the subsets are too small to compare. With improvements in the design of stents, gastroenterologists and thoracic surgeons have broadened the indications for stent placement to encompass benign strictures, perforations, and anastomotic leakage after gastroesophageal resections. 12 Although the palliation of inoperable malignant obstruction remains the most common indication of esophageal stenting in the literature, 11 patients with any gastroesophageal leak also can be successfully managed with endoscopic intervention and subsequent salvage of the native organs. With our proposed algorithm (Figure 1 ), we report a clinical success with 81.9% of our patients at a single institution, defined as resolution of gastric/esophageal leak or obstruction secondary to stricture without either takedown of the esophageal conduit, esophagectomy, or gastrectomy. Similar to our findings, a systematic review of 25 articles by van Boeckel and colleagues 15 that included 267 patients (51% anastomotic leak, 25% iatrogenic perforation, 17% spontaneous perforation) had reported 85% success with endoscopic treatment of anastomotic leak with esophageal stent. 1 Potential complications from esophageal stent insertion include perforation, erosion, bronchoesophageal fistula, and recurrent obstruction due to tumor ingrowth. As in any iatrogenic esophageal perforation, stent-related perforation can be a life-threatening event. There are various reports of complications in the literature secondary to stent, such as perforation into the trachea 16 and esophageal necrosis at the proximal end of stent, 17 as well as enlargement of the esophageal leak 4 and extension of anastomotic dehiscence. 18 However, the only esophageal perforation we experienced in our study was a result of the initial stent with no distal obstruction that was diagnosed in a timely manner before clinical deterioration, which resolved after stent exchange. Our one listed mortality was from a patient who had presented to us in extremis and was not directly related to the stent itself.
Study Limitations
Our study has the limitations inherent to all retrospective outcome studies. Our study consisted of a small and heterogeneous group of patients with an uncommon clinical problem. It is not meaningful to compare leaks and perforations with a stricture population. However, because the main purpose of our study was to demonstrate successful salvage, we decided to include refractory strictures as candidates for stent, because if these patients failed conservative therapy with serial dilations, they would be eventually counseled to undergo an esophagectomy or risk an iatrogenic perforation with repeated dilations and trauma. Although a comparison group of patients without stent therapy would be beneficial to demonstrate the efficacy of stent use, we cannot provide such a group because stent therapy has primarily become the standard of care at our institution for this patient population over the past 10 years. Furthermore, there is a selection bias inherent to this study. Because a septic, clinically unstable patient would not have been considered for a stent and may have indeed undergone a diversion, and because this study is focused on those patients who were initially treated with a stent, it has automatically excluded those patients who were not candidates for stenting to begin with; this may have resulted in a falsely elevated salvage rate. And finally, the study is limited by our inpatient data only (as we did not have outpatient follow-up data or information on death from other causes) and the use of covered and partially covered stents without any strict guidelines. Although the judgment to place cSEMS versus pcSEMS was dependent on the surgeon's discretion, some of the criteria used at our institution to place covered stents were as follows: cSEMS were chosen if the leak, perforation, or stricture site was very high and close to the upper esophageal sphincter to avoid the uncovered portion of the stent to cause neck pain and persisting globus sensation. Additionally, patients with friable esophagus whereby the uncovered portion of the stent could result in granulation tissue formation that could then cause significant injury during stent removal were considered an ideal group of patients for cSEMS; these were concomitantly anchored, as covered stents are anecdotally at higher risk for migration. Despite these limitations, our study is one of the largest case series currently available, and is unique in that we included all patients with gastroesophageal leakage who underwent endoscopic management and all patients with stricture who had failed repeated dilations and would have otherwise needed an esophagectomy.
Given our experience and outcome, we have proposed an algorithm ( Figure 1 ) on how to evaluate patients for stent placement versus definitive repair or even diversion. Furthermore, we are not suggesting that all spontaneous perforations be handled with stents; indeed, we recommend that if a patient has a spontaneous perforation with frank extravasation into the pleural space or gross contamination of the mediastinum, a thoracoscopic or even open washout is warranted, along with a primary repair of the perforation site with a muscle flap or even diversion. However, if a patient suffers from rather limited perforation or incidental pneumomediastinum whereby the esophagram demonstrates the contrast to be walled off with little or no spillage, a stent can be considered as long as the patient is hemodynamically stable.
CONCLUSIONS
Based on our study presented here, we recommend the use of SEMS in a carefully selected patient population, with an acceptable salvage success. We have hereby proposed an algorithm highlighting the criteria to decide when to stent patients and demonstrated 2 techniques that we use at our institution to anchor stents to decrease the incidence of migration (Video 1).
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